467 related articles for article (PubMed ID: 25337276)
1. Evaluation of serum anti-Mullerian hormone as a biomarker of early ovarian aging in young women undergoing IVF/ICSI cycle.
Lin PY; Huang FJ; Kung FT; Chiang HJ; Lin YJ; Lin YC; Lan KC
Int J Clin Exp Pathol; 2014; 7(9):6245-53. PubMed ID: 25337276
[TBL] [Abstract][Full Text] [Related]
2. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
Dai X; Wang Y; Yang H; Gao T; Yu C; Cao F; Xia X; Wu J; Zhou X; Chen L
Sci Rep; 2020 Nov; 10(1):19750. PubMed ID: 33184364
[TBL] [Abstract][Full Text] [Related]
3. Low anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment.
Peuranpää P; Hautamäki H; Halttunen-Nieminen M; Hydén-Granskog C; Tiitinen A
Hum Reprod; 2020 Mar; 35(3):504-515. PubMed ID: 32219343
[TBL] [Abstract][Full Text] [Related]
4. The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive age.
Lee RK; Wu FS; Lin MH; Lin SY; Hwu YM
Reprod Biol Endocrinol; 2011 Aug; 9():115. PubMed ID: 21843363
[TBL] [Abstract][Full Text] [Related]
5. The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization.
Reijnders IF; Nelen WL; IntHout J; van Herwaarden AE; Braat DD; Fleischer K
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():45-50. PubMed ID: 26967346
[TBL] [Abstract][Full Text] [Related]
6. Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve.
Lunding SA; Pors SE; Kristensen SG; Landersoe SK; Jeppesen JV; Flachs EM; Pinborg A; Macklon KT; Pedersen AT; Andersen CY; Andersen AN
Hum Reprod; 2019 Oct; 34(10):1924-1936. PubMed ID: 31593582
[TBL] [Abstract][Full Text] [Related]
7. Delay in IVF treatment up to 180 days does not affect pregnancy outcomes in women with diminished ovarian reserve.
Romanski PA; Bortoletto P; Rosenwaks Z; Schattman GL
Hum Reprod; 2020 Jul; 35(7):1630-1636. PubMed ID: 32544225
[TBL] [Abstract][Full Text] [Related]
8. Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance.
Morin SJ; Patounakis G; Juneau CR; Neal SA; Scott RT; Seli E
Hum Reprod; 2018 Aug; 33(8):1489-1498. PubMed ID: 30010882
[TBL] [Abstract][Full Text] [Related]
9. Cumulative live birth rates in low-prognosis women.
Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; van Golde RJT; Hoek A; Lambalk CB; de Bruin JP; Fleischer K; Mochtar MH; Kuchenbecker WKH; Laven JSE; Mol BWJ; Torrance HL; Broekmans FJM;
Hum Reprod; 2019 Jun; 34(6):1030-1041. PubMed ID: 31125412
[TBL] [Abstract][Full Text] [Related]
10. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
Polyzos NP; Nelson SM; Stoop D; Nwoye M; Humaidan P; Anckaert E; Devroey P; Tournaye H
Fertil Steril; 2013 Aug; 100(2):438-44. PubMed ID: 23602319
[TBL] [Abstract][Full Text] [Related]
11. Basal serum anti-Mullerian hormone (AMH) is a promising test in prediction of occurrence of pregnancy rate in infertile women undergoing ICSI cycles.
Kamel HM; Amin AH; Al-Adawy AR
Clin Lab; 2014; 60(10):1717-23. PubMed ID: 25651719
[TBL] [Abstract][Full Text] [Related]
12. Serum anti-Müllerian hormone levels are associated with early miscarriage in the IVF/ICSI fresh cycle.
Liu X; Han Y; Wang X; Zhang Y; Du A; Yao R; Lv J; Luo H
BMC Pregnancy Childbirth; 2022 Apr; 22(1):279. PubMed ID: 35366830
[TBL] [Abstract][Full Text] [Related]
13. Random anti-Müllerian hormone predicts ovarian response in women with high baseline follicle-stimulating hormone levels : anti-Müllerian hormone in poor responders in assisted reproductive treatment.
Celik H; Bıldırcın D; Güven D; Cetinkaya MB; Alper T; Batuoğlu AS
J Assist Reprod Genet; 2012 Aug; 29(8):797-802. PubMed ID: 22573035
[TBL] [Abstract][Full Text] [Related]
14. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
15. Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles.
La Marca A; Minasi MG; Sighinolfi G; Greco P; Argento C; Grisendi V; Fiorentino F; Greco E
Fertil Steril; 2017 Nov; 108(5):777-783.e2. PubMed ID: 28987789
[TBL] [Abstract][Full Text] [Related]
16. Ovarian Endometrioma Negatively Impacts Oocyte Quality and Quantity But Not Pregnancy Outcomes in Women Undergoing IVF/ICSI Treatment: A Retrospective Cohort Study.
Wu Y; Yang R; Lan J; Lin H; Jiao X; Zhang Q
Front Endocrinol (Lausanne); 2021; 12():739228. PubMed ID: 34880831
[TBL] [Abstract][Full Text] [Related]
17. Antimüllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization.
Hamdine O; Eijkemans MJC; Lentjes EGW; Torrance HL; Macklon NS; Fauser BCJM; Broekmans FJ
Fertil Steril; 2015 Oct; 104(4):891-898.e2. PubMed ID: 26196233
[TBL] [Abstract][Full Text] [Related]
18. Serum anti-Müllerian hormone levels are associated with perinatal outcomes in women undergoing IVF/ICSI: A multicenter retrospective cohort study.
He YC; Su KZ; Cai J; Meng QX; Wu YT; Huang HF
Front Endocrinol (Lausanne); 2023; 14():1081069. PubMed ID: 36896183
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Anti-Müllerian Hormone and
Sun XY; Lan YZ; Liu S; Long XP; Mao XG; Liu L
Front Endocrinol (Lausanne); 2020; 11():595448. PubMed ID: 33343511
[TBL] [Abstract][Full Text] [Related]
20. High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients.
Guo Y; Liu S; Hu S; Li F; Jin L
Front Endocrinol (Lausanne); 2021; 12():673284. PubMed ID: 34122349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
